In 2015, experts diagnosed Chris Long with acute myeloid leukemia and myelodysplastic syndrome. But to Chris, those scientific phrases meant blood cancer. Patients with acute myeloid leukemia (AML) have a 24% likelihood of survival.

The father of two had an aberrant tumor in his bone marrow, infecting his blood cells. The sole therapeutic option is to combine chemotherapy and a bone marrow transplant. While considering his options, Chris realized that his future was grim.